Miles Flamenbaum

Miles Flamenbaum is an experienced corporate development advisor and executive with a strong track record in leading and commercializing advanced technology initiatives across various industries. Currently serving as a Corporate Development Advisor at Stuart Therapeutics since June 2024, Flamenbaum has also held significant roles at Actasys, including Director on the Board of Directors and Chief Executive Officer, where leadership in venture capital-backed projects led to partnerships with major global companies such as Volvo and Alstom. Previously, Flamenbaum founded and led SOMS Technologies, achieving notable growth in clean technology, and held key strategic positions at Medical Instill Technologies and Oxford GlycoSciences, focusing on business development and technology licensing. Educational qualifications include a JD from Brooklyn Law School, an Executive Certificate in Mergers and Acquisitions from London Business School, an MA in International Relations from Boston University, and a BA in Political Science from Franklin & Marshall College.